tiprankstipranks
Trending News
More News >
Altria Group Inc (MO)
NYSE:MO
Advertisement

Altria Group (MO) AI Stock Analysis

Compare
18,378 Followers

Top Page

MO

Altria Group

(NYSE:MO)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - 4o)
Rating:66Neutral
Price Target:
$67.00
▲(15.46% Upside)
Altria's overall stock score reflects strong valuation and earnings call performance, offset by financial risks due to high leverage and bearish technical indicators. The company's strategic initiatives and high dividend yield are positive, but declining cigarette volumes and competitive pressures in the nicotine pouch market pose challenges.
Positive Factors
Strong Cash Flow Generation
Strong cash flow generation enhances Altria's ability to invest in growth opportunities and return value to shareholders, supporting long-term financial stability.
Growth in Oral Tobacco Products
Growth in oral tobacco products indicates successful diversification efforts, reducing reliance on traditional cigarettes and aligning with evolving consumer preferences.
Increased EPS Guidance
Raising EPS guidance reflects management's confidence in future performance, suggesting strong operational execution and strategic positioning.
Negative Factors
Declining Cigarette Volumes
Declining cigarette volumes highlight challenges in the core business, potentially impacting revenue and necessitating a shift towards alternative products.
High Leverage and Negative Equity
High leverage and negative equity pose financial risks, limiting flexibility and increasing vulnerability to economic downturns or regulatory changes.
Increased Competition in Nicotine Pouch Market
Increased competition in the nicotine pouch market could pressure margins and market share, challenging Altria's growth in this segment.

Altria Group (MO) vs. SPDR S&P 500 ETF (SPY)

Altria Group Business Overview & Revenue Model

Company DescriptionAltria Group, Inc. is a leading American corporation primarily engaged in the manufacture and sale of tobacco products. The company operates through several segments, including smokeable products, smokeless products, and wine. Altria's core products include well-known cigarette brands such as Marlboro, as well as smokeless tobacco products like Copenhagen and Skoal. In recent years, Altria has also expanded its portfolio to include heated tobacco products and e-vapor products, reflecting a strategic shift towards reduced-risk alternatives.
How the Company Makes MoneyAltria generates revenue predominantly through the sale of its tobacco products, which are subject to various federal and state taxes. The company's primary revenue stream comes from its smokeable products, particularly cigarettes, which account for a significant portion of its sales. Additionally, Altria earns revenue from its smokeless tobacco products and wines. The company's revenue model is heavily influenced by pricing strategies, including the adjustment of product prices in response to taxation and regulatory changes. Altria also engages in strategic partnerships and investments in emerging markets, particularly in reduced-risk products like IQOS, a heated tobacco product. These partnerships and investments aim to capture market share in the evolving landscape of tobacco consumption, contributing to the company's overall earnings.

Altria Group Key Performance Indicators (KPIs)

Any
Any
Smokeable Products Sticks Shipped
Smokeable Products Sticks Shipped
Indicates the volume of cigarette products distributed, reflecting consumer demand trends and market penetration for Altria's smokeable segment.
Chart InsightsAltria's smokeable products segment is experiencing a significant decline in cigarette volumes, with Marlboro and other premium brands seeing consistent decreases. Despite Marlboro's leadership in the premium segment, the decline aligns with broader industry trends and regulatory pressures. The earnings call highlighted a 10.2% drop in domestic cigarette volumes in Q2, emphasizing the need for strategic pivots. Altria is focusing on growth in the oral tobacco segment, particularly with on! nicotine pouches, which could offset some of the declines in traditional cigarette sales.
Data provided by:Main Street Data

Altria Group Earnings Call Summary

Earnings Call Date:Oct 30, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Jan 29, 2026
Earnings Call Sentiment Neutral
Altria's earnings call presented a strong financial performance with increased earnings and strategic initiatives such as a dividend increase, share repurchase program, and new product launches. However, challenges like cigarette volume decline and intensified competition in the nicotine pouch market were notable. Regulatory advancements and new collaborations were positive highlights.
Q3-2025 Updates
Positive Updates
Strong Financial Performance
Altria delivered a 3.6% increase in adjusted diluted earnings per share for the third quarter and a 5.9% increase for the first nine months.
Dividend and Share Repurchase Program
In August, Altria announced its 60th dividend increase in 56 years and expanded its share repurchase program to $2 billion.
On! PLUS Launch
Helix launched on! PLUS in Florida, North Carolina, and Texas, with positive consumer feedback indicating potential for premium positioning.
Regulatory Progress
The FDA's pilot program aims to accelerate PMTA reviews for oral nicotine pouches, including applications for on! PLUS.
KT&G Collaboration
Altria announced a collaboration with KT&G to explore global demand for nicotine pouch products and opportunities in U.S. non-nicotine markets.
Negative Updates
Cigarette Volume Decline
Smokeable products segment reported an 8.2% decline in domestic cigarette volumes for the third quarter.
Intensified Competition in Nicotine Pouches
Competitors' promotional activity led to a decline in retail prices for nicotine pouches by 7% nationally.
E-Vapor Market Challenges
The e-vapor market remains saturated with illicit products, and NJOY and JUUL initiated litigation against each other.
Company Guidance
During the Altria Group's 2025 Third Quarter Earnings Conference Call, the company provided guidance highlighting strong financial performance and strategic advancements. For the third quarter, Altria reported a 3.6% increase in adjusted diluted earnings per share, with the smokeable products segment showing a 0.7% growth in adjusted operating company's income, reaching nearly $3 billion. The adjusted OCI margins expanded to 64.4%, despite a domestic cigarette volume decline of 8.2%. The oral tobacco segment, bolstered by the Helix brand, particularly on! nicotine pouches, saw a retail share increase to 8.7%, with shipment volumes growing by 1% despite competitive pressures. Altria raised the lower end of its 2025 guidance range, now anticipating adjusted diluted EPS growth of 3.5% to 5%. The company also highlighted its strategic collaboration with KT&G to explore international markets and non-nicotine products, alongside regulatory advancements for its smoke-free portfolio, including the launch of on! PLUS and regulatory filings for heated tobacco products. Altria remains committed to shareholder returns, evidenced by its recent dividend increase and share repurchase program expansion.

Altria Group Financial Statement Overview

Summary
Altria Group demonstrates robust operational efficiency and strong cash flow generation, with a high gross profit margin of 71.63% and a solid EBIT margin of 54.56%. However, challenges include declining revenue, a significant drop in net profit margin to 43.39%, and high leverage reflected in negative stockholders' equity.
Income Statement
70
Positive
Altria Group's income statement shows a stable but declining revenue trend with a slight decrease from the previous year. The gross profit margin stands at a strong 71.63% for TTM (Trailing-Twelve-Months), indicating efficient cost management. However, the net profit margin has decreased significantly from 55.08% in 2024 to 43.39% in the TTM, reflecting potential challenges in maintaining profitability. The EBIT margin remains robust at 54.56%, demonstrating solid operational efficiency.
Balance Sheet
55
Neutral
The balance sheet reveals a concerning negative stockholders' equity of -3,256 million USD as of TTM, indicative of high leverage and potential risk. The debt-to-equity ratio is not applicable due to negative equity, but the high level of debt poses a risk of financial instability. The equity ratio is negative, emphasizing the need for capital restructuring to enhance financial health.
Cash Flow
75
Positive
Cash flow analysis highlights a strong free cash flow growth rate of 24.63% in the TTM, driven by effective capital expenditure management. The operating cash flow to net income ratio is 1.24, suggesting strong cash generation capabilities relative to net earnings. The free cash flow to net income ratio is 1.22, reinforcing the company's ability to generate cash. However, significant financing cash outflows may affect future liquidity.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue20.17B20.44B20.50B20.69B21.11B20.84B
Gross Profit14.52B14.37B14.28B14.25B13.99B13.02B
EBITDA12.10B15.07B12.35B8.74B5.26B8.37B
Net Income8.87B11.26B8.13B5.76B2.48B4.47B
Balance Sheet
Total Assets0.0035.18B38.57B36.95B39.52B47.41B
Cash, Cash Equivalents and Short-Term Investments0.003.13B3.69B4.03B4.54B4.95B
Total Debt25.70B24.93B26.23B26.68B28.04B29.47B
Total Liabilities37.60B37.37B42.06B40.88B41.13B44.49B
Stockholders Equity-2.65B-2.24B-3.54B-3.97B-1.61B2.84B
Cash Flow
Free Cash Flow11.57B8.61B9.09B8.05B8.24B8.15B
Operating Cash Flow11.75B8.75B9.29B8.26B8.40B8.38B
Investing Cash Flow-203.00M2.17B-1.28B782.00M1.21B-143.00M
Financing Cash Flow-3.56B-11.49B-8.37B-9.54B-10.03B-5.40B

Altria Group Technical Analysis

Technical Analysis Sentiment
Negative
Last Price58.03
Price Trends
50DMA
63.96
Negative
100DMA
62.33
Negative
200DMA
58.65
Negative
Market Momentum
MACD
-2.12
Positive
RSI
31.95
Neutral
STOCH
16.03
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MO, the sentiment is Negative. The current price of 58.03 is below the 20-day moving average (MA) of 61.76, below the 50-day MA of 63.96, and below the 200-day MA of 58.65, indicating a bearish trend. The MACD of -2.12 indicates Positive momentum. The RSI at 31.95 is Neutral, neither overbought nor oversold. The STOCH value of 16.03 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MO.

Altria Group Risk Analysis

Altria Group disclosed 23 risk factors in its most recent earnings report. Altria Group reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Altria Group Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
$1.91B35.2822.54%0.29%6.71%8.16%
67
Neutral
$2.81B28.104.56%0.34%61.64%16.76%
66
Neutral
$96.14B10.937.10%-0.96%-11.42%
64
Neutral
$1.37B12.377.72%6.26%3.01%-7.14%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
62
Neutral
$233.34B27.153.60%7.72%-12.45%
52
Neutral
$119.12B30.005.97%5.48%0.48%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MO
Altria Group
58.03
7.76
15.45%
BTI
British American Tobacco
54.59
21.81
66.55%
PM
Philip Morris
153.39
32.94
27.35%
UVV
Universal
53.32
2.94
5.84%
TPB
Turning Point Brands
103.00
50.72
97.02%
RLX
RLX Technology
2.32
0.73
46.10%

Altria Group Corporate Events

Altria’s 2025 Earnings Report and Strategic Moves
Oct 31, 2025

Altria Group, Inc., a prominent player in the tobacco industry, is known for its diverse portfolio of tobacco products, including both combustible and smoke-free offerings, as well as its strategic investments in related sectors. The company recently released its third-quarter and nine-month financial results for 2025, highlighting a narrowed full-year earnings guidance and an expanded share repurchase program.

Business Operations and StrategyStock BuybackFinancial Disclosures
Altria Expands Share Repurchase Program to $2 Billion
Positive
Oct 30, 2025

On October 29, 2025, Altria’s Board of Directors authorized the expansion of its share repurchase program from $1 billion to $2 billion, set to expire on December 31, 2026. The company reported its third-quarter and nine-month results for 2025, highlighting resilience in its core tobacco businesses and advancements in its smoke-free portfolio. Altria also narrowed its full-year earnings guidance for 2025, expecting adjusted diluted EPS growth of 3.5% to 5.0% from 2024. The company continues to focus on returning value to shareholders through dividends and share repurchases while pursuing long-term growth in smoke-free and non-nicotine products.

The most recent analyst rating on (MO) stock is a Sell with a $57.00 price target. To see the full list of analyst forecasts on Altria Group stock, see the MO Stock Forecast page.

Executive/Board Changes
Altria Group Announces Board Member Retirement
Neutral
Oct 9, 2025

On October 3, 2025, Altria Group announced the retirement of George Muñoz from its Board of Directors, effective after his current term ends. Muñoz, who has been with Altria since 2004, will not seek re-election at the 2026 Annual Meeting of Shareholders. His departure marks the end of over two decades of significant contributions to the company, where he held key roles such as Chair of the Compensation and Talent Development Committee. This change in leadership could impact Altria’s strategic direction as it continues to pursue its vision of a smoke-free future.

The most recent analyst rating on (MO) stock is a Buy with a $72.00 price target. To see the full list of analyst forecasts on Altria Group stock, see the MO Stock Forecast page.

Private Placements and Financing
Altria Group Issues $1 Billion in Senior Notes
Neutral
Aug 6, 2025

On August 6, 2025, Altria Group issued $1 billion in senior unsecured notes, split evenly between 4.500% Notes due 2030 and 5.250% Notes due 2035. This financial move, guaranteed by Philip Morris USA, aims to strengthen Altria’s capital structure and maintain its competitive positioning in the market.

The most recent analyst rating on (MO) stock is a Hold with a $59.00 price target. To see the full list of analyst forecasts on Altria Group stock, see the MO Stock Forecast page.

Altria Reports Q2 2025 Earnings Amid Challenges
Jul 31, 2025

Altria Group, Inc., a leading player in the tobacco industry, is engaged in the manufacture and sale of cigarettes, cigars, smokeless tobacco, and e-vapor products in the United States. The company also holds investments in Anheuser-Busch InBev and Cronos Group, diversifying its portfolio beyond traditional tobacco products.

Altria’s Earnings Call: Mixed Results and Strategic Moves
Jul 31, 2025

Altria’s recent earnings call painted a mixed picture of the company’s current standing and future prospects. While the company demonstrated strong financial performance, particularly with the growth of its on! nicotine pouches and significant shareholder returns, it also faced notable challenges. These included a decline in cigarette volumes, legal setbacks with NJOY, and regulatory hurdles in the e-vapor market. Altria is actively making strategic moves to address these issues, but some challenges remain significant.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 31, 2025